Olink to participate in September investor conferences
30. August 2022 08:00 ET
|
Olink Proteomics AB
UPPSALA, Sweden, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that Company management will participate in the following investor conferences: ...
Olink reports second quarter 2022 financial results
11. August 2022 07:00 ET
|
Olink Proteomics AB
UPPSALA, Sweden, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the second quarter of 2022. Highlights ...
Olink reports second quarter 2022 financial results
11. August 2022 07:00 ET
|
Olink Proteomics AB
UPPSALA, Sweden, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the second quarter of 2022. Highlights Second...
Olink to report second quarter 2022 financial results on August 11, 2022
14. Juli 2022 08:00 ET
|
Olink Proteomics AB
UPPSALA, Sweden, July 14, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced it will release financial results for the second quarter of 2022 before the market...
Olink to report second quarter 2022 financial results on August 11, 2022
14. Juli 2022 08:00 ET
|
Olink Proteomics AB
UPPSALA, Sweden, July 14, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced it will release financial results for the second quarter of 2022 before the market...
Release of Olink® Analyze 3.1 streamlines proteomic analysis to connect data to biological insight
28. Juni 2022 08:00 ET
|
Olink Proteomics AB
UPPSALA, Sweden, June 28, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced the release of Olink® Analyze 3.1. Olink® Analyze is an R software package, a collection of...
Release of Olink® Analyze 3.1 streamlines proteomic analysis to connect data to biological insight
28. Juni 2022 08:00 ET
|
Olink Proteomics AB
UPPSALA, Sweden, June 28, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced the release of Olink® Analyze 3.1. Olink® Analyze is an R software package, a collection of...
UK Biobank Pharma Proteomics Project publishes early results from its pioneering proteomics research
21. Juni 2022 08:00 ET
|
Olink Proteomics AB
UPPSALA, Sweden, June 21, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) announced that a publication describing the early findings of proteomics research conducted by the UK Biobank...
UK Biobank Pharma Proteomics Project publishes early results from its pioneering proteomics research
21. Juni 2022 08:00 ET
|
Olink Proteomics AB
UPPSALA, Sweden, June 21, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) announced that a publication describing the early findings of proteomics research conducted by the UK Biobank...
Erasmus Medical Center, Rotterdam is partnering with Olink to deepen understanding of disease progression and accelerate the development of novel therapies
16. Juni 2022 08:00 ET
|
Olink Proteomics AB
UPPSALA, Sweden, June 16, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that the Human Genomics Facility of the Erasmus Medical Center in Rotterdam has adopted the...